Clinique de chirurgie digestive et endocrinienne, IMAD, University Hospital Centre, Hotel Dieu, Nantes, France.
Pancreas. 2011 Aug;40(6):920-4. doi: 10.1097/MPA.0b013e31821fd70b.
To compare the clinical outcomes after pancreaticoduodenectomy (PD) in patients older than 70 years old against a matched cohort of patients younger than 70.
A search of the department database revealed that 285 consecutive patients underwent PD from 1996 to 2009. Forty-one patients (14%) were identified to be older than 70 years (group 1), and they were matched with 41 patients younger than 70 (group 2) according to sex, body mass index, American Society of Anesthesiologists score and tumor staging. Medical comorbidities, preoperative CA19-9 and hemoglobin levels, operative and histopathologic data, postoperative course, and survival outcomes were compared between the 2 groups of patients.
Statistical analyses revealed no significant difference between the 2 groups, except for preoperative CA19-9 and hemoglobin levels, operating time, duration of hospitalization, and the number of lymph nodes removed. These parameters, however, did not have an impact on morbidity, mortality, and overall survival.
Based on our study, perioperative morbidity, mortality, and overall survival are not poorer in patients older than 70. Thus, PD should not be contraindicated solely on the basis of chronological age. Moreover, PD can be rationally proposed to patients meeting the "fit elderly" definition.
比较 70 岁以上胰十二指肠切除术(PD)患者与年龄小于 70 岁的匹配队列患者的临床结局。
通过对科室数据库进行检索,发现 1996 年至 2009 年期间有 285 例连续患者接受了 PD。确定 41 例(14%)年龄大于 70 岁(第 1 组),并根据性别、体重指数、美国麻醉医师协会评分和肿瘤分期与 41 例年龄小于 70 岁的患者(第 2 组)进行匹配。比较两组患者的医疗合并症、术前 CA19-9 和血红蛋白水平、手术和组织病理学数据、术后病程和生存结局。
统计分析显示,两组患者除术前 CA19-9 和血红蛋白水平、手术时间、住院时间和淋巴结清扫数外,无统计学差异。然而,这些参数对发病率、死亡率和总生存率没有影响。
根据我们的研究,70 岁以上患者的围手术期发病率、死亡率和总生存率并不差。因此,单纯根据年龄限制 PD 是不合适的。此外,对于符合“健康老年人”定义的患者,可以合理地提出 PD。